Literature DB >> 6699264

Thrombocytopenia induced by pulmonary artery flotation catheters. A prospective study.

J R Vicente Rull, J Loza Aguirre, E de la Puerta, E Moreno Millan, L Peñas Maldonado, C Perez Clausell.   

Abstract

The platelet counts of patients with PAFC were studied prospectively, 45 patients admitted to the ICU during the same period of time, who did not require PAFC were used as a control group. We had previously excluded any other cause of thrombocytopenia in both groups of patients. We found a significant platelet decrease in the PAFC group at 6 h (p less than 0.001), 24 h (p less than 0.001), 48 h (p less than 0.001) and 72 h (p less than 0.001) after catheter placement, compared to the control group. This decrease was early and sharp and disappeared quickly after catheter removal. We believe that thrombocytopenia in these patients is of peripheral origin and is due to an increased consumption of platelets.

Entities:  

Mesh:

Year:  1984        PMID: 6699264     DOI: 10.1007/bf00258065

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  10 in total

1.  A self-guiding catheter for cardiac and pulmonary arterial catheterization and occlusion.

Authors:  M LATEGOLA; H RAHN
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

2.  Letter: Ventricular fibrillation due to passage of a Swan-Ganz catheter.

Authors:  J A Cairns; D Holder
Journal:  Am J Cardiol       Date:  1975-04       Impact factor: 2.778

3.  Use of balloon flotation catheters in critically ill patients.

Authors:  H J Swan; W Ganz
Journal:  Surg Clin North Am       Date:  1975-06       Impact factor: 2.741

4.  Massive thrombosis associated with use of the Swan-Ganz catheter.

Authors:  F H Yorra; R Oblath; H Jaffe; D H Simmons; S E Levy
Journal:  Chest       Date:  1974-06       Impact factor: 9.410

5.  Pulmonary complications of the flow-directed balloon-tipped catheter.

Authors:  G A Foote; S I Schabel; M Hodges
Journal:  N Engl J Med       Date:  1974-04-25       Impact factor: 91.245

6.  Pulmonary artery catheterization in critically ill surgical patients.

Authors:  F Cerra; R Milch; T Z Lajos
Journal:  Ann Surg       Date:  1973-01       Impact factor: 12.969

7.  Perforation of the pulmonary artery by a Swan-Ganz catheter.

Authors:  G M Chun; M H Ellestad
Journal:  N Engl J Med       Date:  1971-05-06       Impact factor: 91.245

8.  Thrombocytopenia and altered platelet kinetics associated with prolonged pulmonary-artery catheterization in the dog.

Authors:  K A Richman; Y L Kim; B E Marshall
Journal:  Anesthesiology       Date:  1980-08       Impact factor: 7.892

9.  Low incidence of thrombocytopenia during treatment with hog mucosa and beef lung heparin.

Authors:  C Eika; H C Godal; K Laake; T Hamborg
Journal:  Scand J Haematol       Date:  1980-07

10.  Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications.

Authors:  G R Rhodes; R H Dixon; D Silver
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

  10 in total
  3 in total

1.  Effects of Baseline Thrombocytopenia and Platelet Decrease Following Renal Replacement Therapy Initiation in Patients With Severe Acute Kidney Injury.

Authors:  Benjamin R Griffin; Anna Jovanovich; Zhiying You; Paul Palevsky; Sarah Faubel; Diana Jalal
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

2.  Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.

Authors:  Fabrice Thiolliere; Anne Françoise Serre-Sapin; Jean Reignier; Marcel Benedit; Jean Michel Constantin; Christine Lebert; Dominique Guélon; Jean François Timsit; Bertrand Souweine
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

3.  Current practice regarding invasive monitoring in intensive care units in Finland. A nationwide study of the uses of arterial, pulmonary artery and central venous catheters and their effect on outcome. The Finnish Intensive Care Study Group.

Authors:  E Saarela; A Kari; P Nikki; V Rauhala; E Iisalo; L Kaukinen
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.